they cant really forecast sales. All you can do is look at the size of the market and estimate what % of the mkt they could get.
If the study is successful and they get reg approval, you would expect them to get a decent part of the mkt. Margins are huge too so they could compete on price if needed.
The result of the clinical study should be out soon. Given the results of the previous study I'd say its unlikely this wont be successful. Will be interesting to see what happens.
they cant really forecast sales. All you can do is look at the...
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
-0.035(6.09%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 57.5¢ | 54.0¢ | $50.49K | 92.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 10880 | 1 |
View Market Depth
| Last trade - 10.30am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
54.0¢ |
Change
-0.035 ( 7.58 %) |
||||
| Open | High | Low | Volume | ||
| 55.0¢ | 56.0¢ | 54.0¢ | 13905 | ||
| Last updated 10.52am 30/05/2024 ? | |||||
| LTP (ASX) Chart |